Nurix Therapeutics, Inc. - COMMON STOCK (NRIX)

CUSIP: 67080M103

Q1 2022 13F Holders as of 31 Mar 2022

Holder snapshot 6 signals
Share change
-38,918
SEC-reported price per share
$14.01
Number of holders
111
Value change
-$19,332,926
Number of buys
63
Number of sells
53
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
103,585,629

Security key

67080M103

Report period

Q1 2022

Institutions

111

Top holders

10

Ownership snapshot

Top reported holders of NRIX - Nurix Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Third Rock Ventures III, ...
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
0/15
Latest evidence
31 Dec 2021
3/4/5 13F Highest disclosed value: $141,018,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

PRICE T ROWE ASSOCIATES INC /MD/ has the largest disclosed position value at $141.02M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PRICE T ROWE ASSOCIATES INC /MD/'s linked filing trail.
Disclosed position value Top 5
Third Rock Ventures III, L.P. $35.1M
COLUMN GROUP L P $14.43M
PRICE T ROWE ASSOCIATES INC /MD/ $141.02M
Redmile Group, LLC $85.64M
BlackRock Finance, Inc. $73.76M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Third Rock Ventures III, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$35,104,359
3,509,348 shares
— 06 May 2021
COLUMN GROUP L P
3/4/5
10%+ Owner
—
denominator unverified
$14,431,862
1,442,739 shares
— 07 May 2021
Jeffrey K. Tong
3/4/5
Director, 10%+ Owner
—
denominator unverified
—
17,500 shares
— 06 May 2021
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$141,018,000
4,871,084 shares
— 31 Dec 2021
Redmile Group, LLC
13F
Company
13F
—
denominator unverified
$85,642,000
2,958,284 shares
— 31 Dec 2021
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$73,761,000
2,547,861 shares
— 31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
111
Shares
40,367,078
Rows available
111
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders
111
Q1 2022 holders
111
Holder diff
0
Investor Q1 2022 Shares Q1 2022 Shares Share Diff Share Chg % Q1 2022 value Q1 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .